Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marco Macagno"'
Autor:
Marco Macagno, Gianluigi De Renzi, Francesca Belardinilli, Giuseppe Giannini, Enrico Cortesi, Ludovic Barault, Simone Bargiacchi, Salvatore Caponnetto, Paola Grammatico, Irene Bottillo, Paola Gazzaniga, Chiara Nicolazzo, Federica Di Nicolantonio
Publikováno v:
Cancer Letters. 507:89-96
The paucity of targeted treatments available in patients with RAS mutant colorectal cancers contributes to the poor prognosis of this patient group compared to those with RAS wild-type disease. Recent liquid biopsy-driven studies have demonstrated th
Autor:
Raffaele A. Calogero, Matteo Curtarello, Marco Macagno, Aichi Msaki, Stefano Indraccolo, Alberto Amadori, Federica Cavallo, Anna Pastò, Maddalena Arigoni, Giuseppina Barutello
Publikováno v:
Oncotarget
// Aichi Msaki 1 , Anna Pasto 1 , Matteo Curtarello 1 , Maddalena Arigoni 2 , Giuseppina Barutello 2 , Raffaele Adolfo Calogero 2 , Marco Macagno 2 , Federica Cavallo 2 , Alberto Amadori 1, 3, * , Stefano Indraccolo 1, * 1 Istituto Oncologico Veneto
Autor:
Stefania Pizzimenti, Federica Cavallo, Ronald Rooke, Maddalena Arigoni, Giuseppina Barrera, Roberto Ruiu, Elisabetta Bolli, Nathalie Accart, Marco Macagno, Raffaele A. Calogero, Luigi Aurisicchio, Stefania Lanzardo, Laura Conti
Resistance to therapy and lack of curative treatments for metastatic breast cancer suggest that current therapies may be missing the subpopulation of chemoresistant and radioresistant cancer stem cells (CSC). The ultimate success of any treatment may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53eeae442edf37abb8b5c1ff217125a5
https://hdl.handle.net/2318/1528949
https://hdl.handle.net/2318/1528949
Autor:
Marco Macagno, Silvio Bandini, Laura Conti, Federica Cavallo, Giuseppina Barutello, Roberto Ruiu, Stefania Lanzardo
Publikováno v:
BioMed Research International, Vol 2014 (2014)
BioMed Research International
BioMed Research International
The tyrosine kinase human epidermal growth factor receptor 2 (HER2) gene is amplified in approximately 20% of human breast cancers and is associated with an aggressive clinical course and the early development of metastasis. Its crucial role in tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8982ab41ec3f0331d87b76f8f4e4b3d2
http://hdl.handle.net/2318/148988
http://hdl.handle.net/2318/148988